clinical patient finder derived

{
  "input": {
    "type": "http",
    "method": "GET",
    "queryParams": {
      "lang": "en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)",
      "phase": "phase2 | phase3 | any (default: any)",
      "country": "Optional country filter — e.g. \"United States\" | \"United Kingdom\" | \"Germany\" | \"Australia\"",
      "condition": "Disease or diagnosis — e.g. \"Glioblastoma\" | \"Sickle Cell Disease\" | \"Cystic Fibrosis\" | \"Huntington Disease\""
    }
  },
  "output": {
    "type": "json",
    "example": {
      "how_to_apply": [
        "Step 1: Confirm eligibility by reviewing inclusion/exclusion criteria with your doctor",
        "Step 2: Identify a participating site near you via the ClinicalTrials.gov \"Find a Location\" tab",
        "Step 3: Request a referral from your oncologist/neurologist to the trial site",
        "Step 4: Expect a screening visit to confirm you meet all criteria — most trials cover this at no cost",
        "Step 5: Informed consent process — you can withdraw at any time without affecting your regular care"
      ],
      "query_summary": {
        "as_of": "2026-06-07",
        "phase": "any",
        "country": null,
        "condition": "Glioblastoma"
      },
      "patient_resources": [
        "ClinicalTrials.gov (clinicaltrials.gov)",
        "National Brain Tumor Society (braintumor.org)",
        "NCI Cancer Information (cancer.gov/about-cancer/treatment/clinical-trials)"
      ],
      "highlighted_trials": [
        {
          "url": "https://clinicaltrials.gov/study/NCT04175171",
          "nctId": "NCT04175171",
          "phase": "PHASE3",
          "title": "Study of Nivolumab Combined With Radiation Therapy in Newly Diagnosed Glioblastoma",
          "status": "RECRUITING",
          "sponsor": "Bristol-Myers Squibb",
          "countries": [
            "United States",
            "United Kingdom",
            "Germany",
            "France",
            "Spain"
          ],
          "contact_hint": "Contact your neuro-oncologist or visit clinicaltrials.gov/study/NCT04175171 for site contacts",
          "who_can_join": "Adults (18+) newly diagnosed with glioblastoma (IDH-wildtype), able to receive radiation therapy. MGMT status: any.",
          "who_cannot_join": "Prior brain tumor treatment, autoimmune conditions requiring systemic steroids, prior immunotherapy.",
          "plain_language_summary": "Comparing a standard radiation + chemotherapy approach vs. adding nivolumab (a cancer immunotherapy drug) in newly diagnosed glioblastoma. For adults newly diagnosed."
        }
      ],
      "recruiting_trials_count": 89
    }
  }
}